Navigation Links
Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease
Date:5/20/2010

Through Existence’s cutting-edge technological advancements, prediction and prevention of a wide range of both common and rare diseases are possible before they ever manifest. The future of medicine starts today.

(PRWEB) May 20, 2010 -- Welcome your new Existence! Existence Genetics LLC, the world’s first predictive medicine company, is working with healthcare providers to PREDICT, PREVENT, and PREVAIL over disease.

Founded in 2005 by a team of physicians, Existence Genetics is pioneering the field of predictive medicine by providing Genetically Tailored Technology to the health care industry. Existence provides health care professionals with access to groundbreaking predictive medicine services and delivers understandable, useful, and personalized solutions to protect and preserve their patients’ health. Rather than simply handing bewildering results to an untrained patient, the goal of Existence is to empower health care professionals with genetic technology so that they can efficiently integrate genetic screening into their practice and provide cutting-edge predictive medicine services to their patients. Because of this, Existence provides its services only through health care professionals and not direct to the consumer (DTC) or over the counter (OTC).

Existence has developed patent-pending Nexus technologies to enable comprehensive genetic testing and analysis that focuses on the personalized prevention of disease. The Nexus technologies include a proprietary, highly advanced gene chip known as the Nexus Gene Chip. This first-of-its-kind, highly accurate gene chip allows cost-effective, time-efficient screening for hundreds of potential disease predispositions as well as for genes that are involved in the prevention and treatment of disease, thereby enabling the advent of genetically tailored prevention. The results provided by the Nexus Gene Chip are analyzed by the Nexus IT system, which uses patent-pending technologies such as the disease matrix, reflex analysis, panel screening, and next-generation genetic reports to provide health care professionals with straightforward, genetically-tailored solutions for their patients.

Existence’s Nexus technologies make predictive medicine straightforward, understandable, useful, and personalized. Existence’s One Genome philosophy means that we focus on all diseases regardless of their prevalence and screen simultaneously for hundreds of rare and common diseases. And because its Nexus technologies were developed with this philosophy in mind, Existence will be the first company that is able to provide full genome clinical analysis of full genome sequencing data.

In addition, Existence’s newest technology, the Pythia Approach, which is now in its final stages of development, combines the genetic analysis of two potential parents to determine the disease predispositions and traits their yet-to-be-conceived offspring are likely to inherit.

Through Existence’s cutting-edge technological advancements, prediction and prevention of a wide range of both common and rare diseases are possible before they ever manifest. The future of medicine starts today.

Existence Genetics has offices in California and New York, with headquarters in Los Angeles. To learn more about Existence Genetics and the Nexus technologies, visit www.existencegenetics.com.

###

Read the full story at http://www.prweb.com/releases/existencegenetics/may2010/prweb4025124.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Georgia DUI Lawyers Scramble to Publicize Existence of New Appeal Fee of $150 for All DUI-Related Administrative License Suspension Cases
2. Medco Acquires Leading Genetics Healthcare Company, DNA Direct
3. New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies
4. Chicago Cancer Genome Project studies genetics of 1,000 tumors
5. Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York
6. Interleukin Genetics, Inc. and Stanford University Report Genetic Test Improves Weight Loss Success With Diets
7. Study finds changes in fetal epigenetics throughout pregnancy
8. Genetics, Psychology May Trigger ADHD
9. Resveratrol Supplement Company RevGenetics Welcomes New Chief Science Officer
10. Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health
11. Cancer genetics pioneer wins Margaret Kripke Legend Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Existence Genetics is Pioneering the Field of Predictive Medicine -  Nexus Technologies Critical in Understanding and Preventing Deadly Disease 
(Date:12/9/2016)... ... 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill the ... amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates ... be set up in a matter of minutes, or even seconds. The SAFETY STRAP ...
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... "I ... said an inventor from Winchester, Va. "I thought that if the nebulizer had a ... treatments rather than fearing them." , He developed the patent-pending NEBY to avoid the ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking ... registration today for its 33rd Annual Issues & Research Conference, March 2-3, ... theme of the conference is “Persistent Challenges and New Opportunities: Using Research to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) ... , the ultimate weight loss and wellness program, at their world headquarters of Omni ... provide immediate and long-term results to anyone seeking weight loss, personal development, a healthy ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... FRISCO, Texas , Dec. 8, 2016 /PRNewswire/ ... new program that brings leading-edge laboratory services and ... the United States , allowing more doctors ... and health care management solutions. Logo ... Hospital systems, under pressure to ...
(Date:12/8/2016)... , December 8, 2016 Information products ... metrics in Scopus , the world,s largest abstract ... access to comprehensive metrics for journals from over 5,000 publishers. The ... which journals to subscribe to and when to adjust a journal,s ... , , ...
Breaking Medicine Technology: